Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|February 22, 2017
Advanced Strategies in Immune Modulation of Cancer Using Lipid-Based NanoparticlesShoshy Mizrahy, Inbal Hazan-Halevy, Dalit Landesman-Milo, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 6, 2016
Immunomodulation of hematological malignancies using oligonucleotides based-nanomedicinesInbal Hazan-Halevy, Dalit Landesman-Milo, Daniel Rosenblum, et al.
Journal of Visualized Experiments : Jove|June 25, 2016
Describing a Transcription Factor Dependent Regulation of the MicroRNA TranscriptomeUri Rozovski, Inbal Hazan-Halevy, George Calin, et al.
Annals of Hematology|February 22, 2012
Increased CD39 expression on CD4(+) T lymphocytes has clinical and prognostic significance in chronic lymphocytic leukemiaChava Perry, Inbal Hazan-Halevy, Sigi Kay, et al.
Molecular Cancer Research : MCR|March 3, 2011
STAT-3 activates NF-kappaB in chronic lymphocytic leukemia cellsZhiming Liu, Inbal Hazan-Halevy, David M Harris, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 14, 2024
The future of genetic medicines delivered via targeted lipid nanoparticles to leukocytesDana Tarab-Ravski, Lior Stotsky-Oterin, Aviad Elisha, et al.
Advanced Materials (Deerfield Beach, Fla.)|January 19, 2022
Dual-Targeted Lipid Nanotherapeutic Boost for Chemo-Immunotherapy of CancerSeok-Beom Yong, Srinivas Ramishetti, Meir Goldsmith, et al.
Blood|February 16, 2010
STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cellsInbal Hazan-Halevy, David Harris, Zhiming Liu, et al.
Advanced Materials (Deerfield Beach, Fla.)|January 31, 2020
A Combinatorial Library of Lipid Nanoparticles for RNA Delivery to LeukocytesSrinivas Ramishetti, Inbal Hazan-Halevy, Ramesh Palakuri, et al.
Pageof 4